These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

635 related items for PubMed ID: 16684011

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Prophylaxis and von Willebrand's disease (vWD).
    Abshire TC.
    Thromb Res; 2006; 118 Suppl 1():S3-7. PubMed ID: 16580053
    [Abstract] [Full Text] [Related]

  • 23. Recessive von Willebrand disease type 2 Normandy: variable expression of mild hemophilia and VWD type 1.
    Michiels JJ, Gadisseur A, Vangenegten I, Schroyens W, Berneman Z.
    Acta Haematol; 2009; 121(2-3):119-27. PubMed ID: 19506358
    [Abstract] [Full Text] [Related]

  • 24. [Desmopressin in hemophilia A and Von Willebrand's disease].
    Castro Cabezas M, de Graaf JC, Kraayenhagen RJ, Freen M, Poortman J, Hart HC.
    Ned Tijdschr Geneeskd; 1991 Mar 02; 135(9):367-71. PubMed ID: 1901629
    [Abstract] [Full Text] [Related]

  • 25. [Von Willebrand disease: characteristics and response to desmopressin. Study of 103 cases].
    César JM, Avello AG, Vecino A, Cerveró C, Laraña JG, Fuertes IF, Villarrubia J, López J, de Oteyza JP, Velasco JL, Cantalapiedra A, Herrera P, Herrero S, Navarro JL.
    Med Clin (Barc); 1998 Nov 14; 111(16):601-3. PubMed ID: 9881332
    [Abstract] [Full Text] [Related]

  • 26. Laboratory diagnosis and molecular classification of von Willebrand disease.
    Gadisseur A, Hermans C, Berneman Z, Schroyens W, Deckmyn H, Michiels JJ.
    Acta Haematol; 2009 Nov 14; 121(2-3):71-84. PubMed ID: 19506352
    [Abstract] [Full Text] [Related]

  • 27. Haemostatic management of intraoral bleeding in patients with von Willebrand disease.
    Morimoto Y, Yoshioka A, Sugimoto M, Imai Y, Kirita T.
    Oral Dis; 2005 Jul 14; 11(4):243-8. PubMed ID: 15984956
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Clinical efficacy in bleeding and surgery in von Willebrand patients treated with Fanhdi a highly purified, doubly inactivated FVIII/VWF concentrate.
    Hernandez-Navarro F, Quintana M, Jimenez-Yuste V, Alvarez MT, Fernandez-Morata R.
    Haemophilia; 2008 Sep 14; 14(5):963-7. PubMed ID: 18624696
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Retrospective review of the management of elective surgery with desmopressin and clotting factor concentrates in patients with von Willebrand disease.
    Nitu-Whalley IC, Griffioen A, Harrington C, Lee CA.
    Am J Hematol; 2001 Apr 14; 66(4):280-4. PubMed ID: 11279640
    [Abstract] [Full Text] [Related]

  • 35. Treatment of von Willebrand's disease.
    Mannucci PM.
    J Intern Med Suppl; 1997 Apr 14; 740():129-32. PubMed ID: 9350194
    [Abstract] [Full Text] [Related]

  • 36. Treatment of urgent bleeding in von Willebrand disease.
    Gill JC.
    Thromb Res; 2007 Apr 14; 120 Suppl 1():S21-5. PubMed ID: 17490729
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 32.